Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Health Canada/NARCAN NASAL SPRAY

Authorized

STANDARD

NARCAN NASAL SPRAY

emergent operations ireland limited🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: 88bcbfccdae955df
Company: emergent operations ireland limited
Type: Standard

Approval Details

Approval Id: 88bcbfccdae955df
Drug Approval Canada Name: NARCAN NASAL SPRAY
Product Name: NARCAN NASAL SPRAY
Status: Marketed
Status Date: 2021-03-09
Original Market Date: 2017-07-07
Din: 02458187
Drug Class: Human
Dosage Form: Spray, Metered Dose
Route Of Administration: Nasal
Schedule: Ethical
Ahfs: 28:10.00
Atc Original: V03AB15 NALOXONE
Atc Name: v 03 ab 15
Aig Number: 0108981005
Company Name: emergent operations ireland limited
Company Address: 6th Earlsfort Terrace, Dublin 2, --, Ireland, D02W773

Active Ingredients

NALOXONE HYDROCHLORIDE

4 MG / 0.1 ML

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

88bcbfccdae955df

Type

Standard

Back to Health Canada Approvals

NARCAN NASAL SPRAY - Health Canada Drug Approval Details